Addgene is a non-profit plasmid repository. Since its founding in 2004, the company provided free resources to facilitate exchange of plasmids across laboratories. Addgene also archives and makes available a free online database of plasmids. We want to thank Addgene for providing us with discounts on plasmid purchases.

Bio Basic Inc. is a privately owned dynamic biotechnology company. The company was founded in 1990 in Toronto, Canada. From 1990 to 1995, Bio Basic Inc.’s primary focus was in the field of biochemicals. Starting in 1995, Bio Basic Inc. began manufacturing various Life Science Products. Over the past two decades, the company has developed rapidly and now serves as a one-stop-shop to researchers in the life sciences field. To date, Bio Basic Inc. has approximately 600 employees, seven laboratories, three factory buildings, 40 international distributors and over 10,000 customers worldwide. The team is grateful for Bio Basic's molecular biology services.

Biomatters/Geneious is a DNA, RNA and protein sequence alignment, assembly and analysis software platform, integrating bioinformatic and molecular biology tools into a simple interface. We thank Geneious for their donated software which helped us design primers and plan our cloning.

The mission of Cornell’s Biotech Institute is to promote research, education and technology transfer for applications of biotechnology for the benefit of the environment, agriculture, engineering and veterinary and human medicine. We would like to thank the institute for their monetary support to the team for the purchasing of laboratory supplies and equipment.

The mission of Cornell’s Biotech Institute is to promote research, education and technology transfer for applications of biotechnology for the benefit of the environment, agriculture, engineering and veterinary and human medicine. We would like to thank the institute for their monetary support to the team for the purchasing of laboratory supplies and equipment.

DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 offers an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline.